| . | Univariable . | . | Multivariable* . | . | ||
|---|---|---|---|---|---|---|
| Variables . | HR . | 95% c.i. . | P . | HR . | 95% c.i. . | P . |
| Age ≥65 years (versus < 65) | 0.88 | 0.49,1.57 | 0.661 | — | — | — |
| Male (versus female) | 0.8 | 0.42,1.54 | 0.512 | — | — | — |
| BMI <18.5 (versus ≥18.5) | 0.89 | 0.45,1.76 | 0.743 | — | — | — |
| ASA III (versus II) | 1.49 | 0.84,2.66 | 0.173 | 0.75 | 0.36,1.56 | 0.435 |
| Charlson Index ≥1 (versus 0) | 0.76 | 0.47,1.75 | 0.903 | — | — | — |
| ECOG 2 (versus 1) | 1.18 | 0.65,2.12 | 0.589 | — | — | — |
| Karnofsky 60–70% (versus 80–90%) | 1.74 | 0.92,3.30 | 0.088 | 0.97 | 0.43,2.17 | 0.934 |
| Haemoglobin <11 g/dl (versus ≥11) | 1.62 | 0.77,3.40 | 0.203 | 1.46 | 0.63,3.38 | 0.382 |
| Initial GOOS 0 (versus 1–2) | 1.62 | 0.83,3.17 | 0.158 | 1.11 | 0.53,2.34 | 0.790 |
| Peritoneal metastasis P1 (versus P0) | 1.2 | 0.67,2.17 | 0.536 | — | — | — |
| Final GOOS 0–1–2 (versus 3) | 7.88 | 3.25,19.08 | <0.001 | 3.58 | 1.10,11.72 | 0.035 |
| Gastrojejunostomy (versus partitioning) | 1.43 | 0.80,2.56 | 0.231 | 0.87 | 0.41,1.84 | 0.720 |
| None (versus chemotherapy) | 5.83 | 2.84,11.98 | <0.001 | 4.97 | 1.85,13.32 | 0.001 |
| . | Univariable . | . | Multivariable* . | . | ||
|---|---|---|---|---|---|---|
| Variables . | HR . | 95% c.i. . | P . | HR . | 95% c.i. . | P . |
| Age ≥65 years (versus < 65) | 0.88 | 0.49,1.57 | 0.661 | — | — | — |
| Male (versus female) | 0.8 | 0.42,1.54 | 0.512 | — | — | — |
| BMI <18.5 (versus ≥18.5) | 0.89 | 0.45,1.76 | 0.743 | — | — | — |
| ASA III (versus II) | 1.49 | 0.84,2.66 | 0.173 | 0.75 | 0.36,1.56 | 0.435 |
| Charlson Index ≥1 (versus 0) | 0.76 | 0.47,1.75 | 0.903 | — | — | — |
| ECOG 2 (versus 1) | 1.18 | 0.65,2.12 | 0.589 | — | — | — |
| Karnofsky 60–70% (versus 80–90%) | 1.74 | 0.92,3.30 | 0.088 | 0.97 | 0.43,2.17 | 0.934 |
| Haemoglobin <11 g/dl (versus ≥11) | 1.62 | 0.77,3.40 | 0.203 | 1.46 | 0.63,3.38 | 0.382 |
| Initial GOOS 0 (versus 1–2) | 1.62 | 0.83,3.17 | 0.158 | 1.11 | 0.53,2.34 | 0.790 |
| Peritoneal metastasis P1 (versus P0) | 1.2 | 0.67,2.17 | 0.536 | — | — | — |
| Final GOOS 0–1–2 (versus 3) | 7.88 | 3.25,19.08 | <0.001 | 3.58 | 1.10,11.72 | 0.035 |
| Gastrojejunostomy (versus partitioning) | 1.43 | 0.80,2.56 | 0.231 | 0.87 | 0.41,1.84 | 0.720 |
| None (versus chemotherapy) | 5.83 | 2.84,11.98 | <0.001 | 4.97 | 1.85,13.32 | 0.001 |
*Variables with P < 0.250 were included in the multivariable model. Bold numbers represent P < 0.005. BMI, body mass index; ASA, American Society of Anesthesiologists; ECOG, Eastern Cooperative Oncology Group; GOOS, Gastric Outlet Obstruction Score.
| . | Univariable . | . | Multivariable* . | . | ||
|---|---|---|---|---|---|---|
| Variables . | HR . | 95% c.i. . | P . | HR . | 95% c.i. . | P . |
| Age ≥65 years (versus < 65) | 0.88 | 0.49,1.57 | 0.661 | — | — | — |
| Male (versus female) | 0.8 | 0.42,1.54 | 0.512 | — | — | — |
| BMI <18.5 (versus ≥18.5) | 0.89 | 0.45,1.76 | 0.743 | — | — | — |
| ASA III (versus II) | 1.49 | 0.84,2.66 | 0.173 | 0.75 | 0.36,1.56 | 0.435 |
| Charlson Index ≥1 (versus 0) | 0.76 | 0.47,1.75 | 0.903 | — | — | — |
| ECOG 2 (versus 1) | 1.18 | 0.65,2.12 | 0.589 | — | — | — |
| Karnofsky 60–70% (versus 80–90%) | 1.74 | 0.92,3.30 | 0.088 | 0.97 | 0.43,2.17 | 0.934 |
| Haemoglobin <11 g/dl (versus ≥11) | 1.62 | 0.77,3.40 | 0.203 | 1.46 | 0.63,3.38 | 0.382 |
| Initial GOOS 0 (versus 1–2) | 1.62 | 0.83,3.17 | 0.158 | 1.11 | 0.53,2.34 | 0.790 |
| Peritoneal metastasis P1 (versus P0) | 1.2 | 0.67,2.17 | 0.536 | — | — | — |
| Final GOOS 0–1–2 (versus 3) | 7.88 | 3.25,19.08 | <0.001 | 3.58 | 1.10,11.72 | 0.035 |
| Gastrojejunostomy (versus partitioning) | 1.43 | 0.80,2.56 | 0.231 | 0.87 | 0.41,1.84 | 0.720 |
| None (versus chemotherapy) | 5.83 | 2.84,11.98 | <0.001 | 4.97 | 1.85,13.32 | 0.001 |
| . | Univariable . | . | Multivariable* . | . | ||
|---|---|---|---|---|---|---|
| Variables . | HR . | 95% c.i. . | P . | HR . | 95% c.i. . | P . |
| Age ≥65 years (versus < 65) | 0.88 | 0.49,1.57 | 0.661 | — | — | — |
| Male (versus female) | 0.8 | 0.42,1.54 | 0.512 | — | — | — |
| BMI <18.5 (versus ≥18.5) | 0.89 | 0.45,1.76 | 0.743 | — | — | — |
| ASA III (versus II) | 1.49 | 0.84,2.66 | 0.173 | 0.75 | 0.36,1.56 | 0.435 |
| Charlson Index ≥1 (versus 0) | 0.76 | 0.47,1.75 | 0.903 | — | — | — |
| ECOG 2 (versus 1) | 1.18 | 0.65,2.12 | 0.589 | — | — | — |
| Karnofsky 60–70% (versus 80–90%) | 1.74 | 0.92,3.30 | 0.088 | 0.97 | 0.43,2.17 | 0.934 |
| Haemoglobin <11 g/dl (versus ≥11) | 1.62 | 0.77,3.40 | 0.203 | 1.46 | 0.63,3.38 | 0.382 |
| Initial GOOS 0 (versus 1–2) | 1.62 | 0.83,3.17 | 0.158 | 1.11 | 0.53,2.34 | 0.790 |
| Peritoneal metastasis P1 (versus P0) | 1.2 | 0.67,2.17 | 0.536 | — | — | — |
| Final GOOS 0–1–2 (versus 3) | 7.88 | 3.25,19.08 | <0.001 | 3.58 | 1.10,11.72 | 0.035 |
| Gastrojejunostomy (versus partitioning) | 1.43 | 0.80,2.56 | 0.231 | 0.87 | 0.41,1.84 | 0.720 |
| None (versus chemotherapy) | 5.83 | 2.84,11.98 | <0.001 | 4.97 | 1.85,13.32 | 0.001 |
*Variables with P < 0.250 were included in the multivariable model. Bold numbers represent P < 0.005. BMI, body mass index; ASA, American Society of Anesthesiologists; ECOG, Eastern Cooperative Oncology Group; GOOS, Gastric Outlet Obstruction Score.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
